Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Genetic Alterations in Differentiated Thyroid Cancers

Author(s): Behrouz Salehian, Zhong Liu and Fouad Kandeel

Volume 9, Issue 3, 2009

Page: [257 - 268] Pages: 12

DOI: 10.2174/187153009789044338

Price: $65

Abstract

Differentiated thyroid cancers are the predominant malignancies of the thyroid. Due to advances in the understanding of the activation of the cell proliferation pathway at a molecular level, multiple genetic alterations have been linked to the development of thyroid carcinogenesis. Although the genetic alterations can be categorized into 7 categories, the BRAF mutation, RET/PTC, Pax8/PPARGamma, and dysfunctional Fas pathway have been most commonly described. Each of the gene alterations can ultimately result in cancer development, invasion and/or metastasis. This article provides a detailed review of the altered cell proliferation pathway activations found in thyroid carcinogenesis. The molecular targets that may be disrupted by therapeutic agents during the abnormal proliferation are also summarized.


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy